全文获取类型
收费全文 | 2359篇 |
免费 | 135篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 76篇 |
妇产科学 | 16篇 |
基础医学 | 618篇 |
口腔科学 | 32篇 |
临床医学 | 193篇 |
内科学 | 380篇 |
皮肤病学 | 89篇 |
神经病学 | 259篇 |
特种医学 | 71篇 |
外科学 | 236篇 |
综合类 | 8篇 |
预防医学 | 147篇 |
眼科学 | 19篇 |
药学 | 134篇 |
中国医学 | 2篇 |
肿瘤学 | 187篇 |
出版年
2022年 | 19篇 |
2021年 | 46篇 |
2020年 | 25篇 |
2019年 | 33篇 |
2018年 | 48篇 |
2017年 | 32篇 |
2016年 | 38篇 |
2015年 | 59篇 |
2014年 | 61篇 |
2013年 | 88篇 |
2012年 | 136篇 |
2011年 | 152篇 |
2010年 | 102篇 |
2009年 | 98篇 |
2008年 | 159篇 |
2007年 | 143篇 |
2006年 | 164篇 |
2005年 | 104篇 |
2004年 | 99篇 |
2003年 | 97篇 |
2002年 | 108篇 |
2001年 | 36篇 |
2000年 | 28篇 |
1999年 | 34篇 |
1998年 | 23篇 |
1997年 | 14篇 |
1996年 | 15篇 |
1994年 | 19篇 |
1993年 | 13篇 |
1992年 | 17篇 |
1991年 | 14篇 |
1990年 | 14篇 |
1988年 | 14篇 |
1987年 | 14篇 |
1978年 | 13篇 |
1975年 | 11篇 |
1972年 | 14篇 |
1939年 | 12篇 |
1938年 | 19篇 |
1937年 | 17篇 |
1931年 | 11篇 |
1930年 | 23篇 |
1929年 | 17篇 |
1928年 | 17篇 |
1927年 | 18篇 |
1926年 | 13篇 |
1925年 | 19篇 |
1924年 | 18篇 |
1923年 | 15篇 |
1922年 | 19篇 |
排序方式: 共有2517条查询结果,搜索用时 234 毫秒
31.
Sonja Loges Gerhard Heil Melanie Bruweleit Volker Schoder Martin Butzal Uta Fischer Ursula M Gehling Gunter Schuch Dieter K Hossfeld Walter Fiedler 《Journal of clinical oncology》2005,23(6):1109-1117
PURPOSE: Bone marrow neoangiogenesis plays an important pathogenetic and possible prognostic role in acute myeloid leukemia (AML). Members of the vascular endothelial growth factor (VEGF) and angiopoietin family represent the most specific inducers of angiogenesis secreted by AML blasts. We therefore correlated expression of angiogenic factors with clinical variables. PATIENTS AND METHODS: We investigated the expression of VEGF-A, VEGF-C, angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), and the receptor Tie2 by quantitative polymerase chain reaction in a cohort of 90 patients younger than 61 years with de novo AML entered into the German AML Süddeutsche H?moblastose Gruppe Hannover 95 trial. Uni- and multivariate analyses were performed using clinical and gene expression variables. RESULTS: Univariate analysis of overall survival indicated the following variables as prognostic factors: good response on a day-15 bone marrow examination after initiation of induction chemotherapy, karyotype, and high Ang2 expression. In multivariate analysis, only bad response and log Ang2 expression remained of statistical significance, with a hazard ratio of 3.51 (95% CI, 1.91 to 6.47) and 0.75 (95% CI, 0.61 to 0.91), respectively. Subgroup analysis suggested that the prognostic impact of Ang2 expression was especially evident in cohorts with low VEGF-C and Ang1 mRNA levels. CONCLUSION: These results show that expression of Ang2 represents an independent prognostic factor in AML. Additional research into interactions of angiogenic cytokines in the pathogenesis of bone marrow angiogenesis in AML is warranted. 相似文献
32.
33.
34.
Pia Klausen Bojan Kovacevic Anders Toxvrd Evangelos Kalaitzakis John Gsdal Karstensen Charlotte Vestrup Rift Carsten Palns Hansen Jan Storkholm Peter Vilmann Jane Preuss Hasselby 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2019,127(1):27-32
Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions of pancreatic ductal adenocarcinoma (PDAC). Current edition of WHO Classification of Tumors of the Digestive System recognizes four different subtypes (gastric, intestinal, pancreatobiliary, and oncocytic) and recommends analysis of mucin expression (MUC1, MUC2, MUC5AC, MUC6) as well as evaluation of architectural and cell differentiation patterns for correct classification. However, there is no consensus on MUC1 expression of IPMN‐lesions in the literature. Current recommendations are based on studies where antibodies against the core MUC1 protein or sialylated MUC1 (tumor associated MUC1), not the fully glycosylated MUC1 were used. We have recently reported that MUC1 is strongly expressed in both gastric and intestinal types IPMN specimens from the cystic wall, obtained by endoscopic ultrasound guided microbiopsy procedure. We have used a commercial MUC1 antibody, validated and recommended for diagnostic use, which recognizes fully glycosylated MUC1. Based on the above, we propose a revision of the WHO Classification, specifying that antibodies against tumor associated MUC1 should be used for IPMN subtyping. 相似文献
35.
36.
Joss von Hadeln Ronja Hensgen Tobias Bockhorst Ronny Rosner Ronny Heidasch Uta Pegel Manuel Quintero Pérez Uwe Homberg 《The Journal of comparative neurology》2020,528(6):906-934
The central complex (CX) comprises a group of midline neuropils in the insect brain, consisting of the protocerebral bridge (PB), the upper (CBU) and lower division (CBL) of the central body and a pair of globular noduli. It receives prominent input from the visual system and plays a major role in spatial orientation of the animals. Vertical slices and horizontal layers of the CX are formed by columnar, tangential, and pontine neurons. While pontine and columnar neurons have been analyzed in detail, especially in the fruit fly and desert locust, understanding of the organization of tangential cells is still rudimentary. As a basis for future functional studies, we have studied the morphologies of tangential neurons of the CX of the desert locust Schistocerca gregaria. Intracellular dye injections revealed 43 different types of tangential neuron, 8 of the PB, 5 of the CBL, 24 of the CBU, 2 of the noduli, and 4 innervating multiple substructures. Cell bodies of these neurons were located in 11 different clusters in the cell body rind. Judging from the presence of fine versus beaded terminals, the vast majority of these neurons provide input into the CX, especially from the lateral complex (LX), the superior protocerebrum, the posterior slope, and other surrounding brain areas, but not directly from the mushroom bodies. Connections are largely subunit- and partly layer-specific. No direct connections were found between the CBU and the CBL. Instead, both subdivisions are connected in parallel with the PB and distinct layers of the noduli. 相似文献
37.
38.
39.
S. Macherey S.F. Preuss F. Doerr S. Grönke M. Heldwein A. Quaas T. Zander K. Hekmat 《HNO》2014,62(12):893-904
Pulmonary metastasectomy is an established procedure in oncological therapeutic concepts. A systematic literature search and an analysis of all studies published since 01.01.2000 should evaluate the advantage of pulmonary metastasectomy for patients with primary head and neck cancer. Lung metastases develop in 1.9–13?% of head and neck cancer patients. Following metastasectomy, patients reach a median survival of 9.5–78 months and 5-year survival rates of up to 58?% are achieved. Intrathoracic recurrence occurs in 18.4–81.8?% of patients, selected instances of which can be successfully treated by remetastasectomy. Patients with squamous cell carcinoma have the worst prognosis, but could also become long-term survivors (≥?60 months). Pulmonary metastasectomy is frequently the only potentially curative therapeutic approach and offers a better long-term survival than nonsurgical therapies. Lung metastasectomy is thus the treatment of choice in selected patients with pulmonary metastases from primary head and neck cancer. 相似文献
40.
Depression and Anxiety Predict Decline in Physical Health Functioning in Patients with Heart Failure
Biing-Jiun Shen Stacy A. Eisenberg Uta Maeda Kristin A. Farrell Ernst R. Schwarz Frank J. Penedo Eugene J. Bauerlein Stephen Mallon 《Annals of behavioral medicine》2011,41(3):373-382